Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients

Authors: Azzahhafi, Jaouad ^{a, ∗, ∗}, van den Broek, Wout W.A. ^a, Chan Pin Yin, Dean R.P.P. ^a, van der Sangen, Niels M.R. ^b, Sivanesan, Shabiga ^b, Bofarid, Salahodin ^a, Peper, Joyce ^a, Claassens, Daniel M.F. ^c, Janssen, Paul W.A. ^d, Harmsze, Ankie M. ^e, Walhout, Ronald J. ^f, Tjon Joe Gin, Melvyn ^g, Nicastia, Deborah M. ^h, Langerveld, Jorina ⁱ, Vlachojannis, Georgios J. ^j, van Bommel, Rutger J. ^k, Appelman, Yolande ^l, van Schaik, Ron H.N. ^m, Henriques, José P.S. ^b, Kikkert, Wouter J. ^{b, k}, ten Berg, Jurriën M. ^{a, n}

Source: In JACC: Cardiovascular Interventions 9 September 2024 17(17):1996-2007

The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study

Authors: bij de Weg, Jeske M., Landman, Anadeijda J.E.M.C., de Vries, Johanna I.P., Thijs, Abel, Harmsze, Ankie M., Oudijk, Martijn A., de Boer, Marjon A.

Source: In European Journal of Obstetrics & Gynecology and Reproductive Biology November 2022 278:67-71

Increased frequency of CYP2C19 loss‐of‐function alleles in clopidogrel‐treated patients with recurrent cerebral ischemia

Authors: Minderhoud, Crista, Otten, Leila S., Hilkens, Pieter H. E., Broek, Marcel P. H., Harmsze, Ankie M.

Source: British journal of clinical pharmacology. 88(7):3335-3340

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100153621710.0x000001&indx=1&recIds=ETOCvdc_100153621710.0x000001

Resistance of aspirin during and after pregnancy: A longitudinal cohort study

Authors: bij de Weg, Jeske M., Abheiden, Carolien N.H., Fuijkschot, Wessel W., Harmsze, Ankie M., de Boer, Marjon A., Thijs, Abel, de Vries, Johanna I.P.

Source: In Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health January 2020 19:25-30

Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions

Authors: Zhang, Zhu Xian, Garde, Ewoudt M. W., Söhne, Maaike, Harmsze, Ankie M., Broek, Marcel P. H.

Source: British journal of clinical pharmacology. 86(8):1567-1574

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100107398224.0x000001&indx=1&recIds=ETOCvdc_100107398224.0x000001

Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.

Authors: Drent, Marjolein, Wijnen, Petal A., Jessurun, Naomi T., Harmsze, Ankie M., Bekers, Otto, Bast, Aalt

Source: Drug Safety; Apr2024, Vol. 47 Issue 4, p355-363, 9p

Subject Terms: INTERSTITIAL lung diseases, LUNGS, DRUG side effects, IDIOPATHIC pulmonary fibrosis, PULMONARY fibrosis, CYTOCHROME P-450, CYTOCHROME P-450 CYP2D6

Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy

Authors: Abheiden, Carolien N.H., Fuijkschot, Wessel W., Arduç, Arda, van Diemen, Jeske J.K., Harmsze, Ankie M., de Boer, Marjon A., Thijs, Abel, de Vries, Johanna I.P.

Source: In European Journal of Obstetrics and Gynecology March 2017 210:139-143

Authors' response to Letter to the Editor on The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study

Authors: bij de Weg, Jeske M., Landman, Anadeijda J.E.M.C., de Vries, Johanna I.P., Thijs, Abel, Harmsze, Ankie M., Oudijk, Martijn A., de Boer, Marjon A.

Source: European journal of obstetrics, gynecology, and reproductive biology. 282:172-172

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184645586.0x000001&indx=1&recIds=ETOCvdc_100184645586.0x000001

CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel

Authors: Peters, Bas JM, Harmsze, Ankie M, ten Berg, Jurriën M, Maitland-van der Zee, Anke-Hilse, Tjoeng, Mathieu M, de Boer, Anthonius, Deneer, Vera HM

Source: Pharmacogenomics. 12(2):141-144

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121256585.0x000001&indx=1&recIds=ETOCvdc_100121256585.0x000001

The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry.

Authors: Azzahhafi, Jaouad, Broek, Wout W. A. van den, Chan Pin Yin, Dean R. P. P., Harmsze, Ankie M., van Schaik, Ron H. N., ten Berg, Jurriën M.

Source: Journal of Cardiovascular Pharmacology & Therapeutics; Jan-Dec2023, Vol. 28, p1-9, 9p

Subject Terms: ACUTE coronary syndrome, PRASUGREL, CYTOCHROME P-450 CYP2C19, PHYSICIAN adherence, TURNAROUND time, COST control

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study.

Authors: van Uden, Renate C. A. E., van den Broek, Marcel P. H., Houtenbos, Ilse, Jaspers, Tessa C. C., Harmsze, Ankie M., Kingma, Hylke J., Odekerken, Diego A. M., Meijer, Karina, van den Bemt, Patricia M. L. A., Becker, Matthijs L.

Source: European Journal of Clinical Pharmacology; Dec2021, Vol. 77 Issue 12, p1919-1926, 8p, 1 Illustration, 4 Charts

Subject Terms: FIBRINOLYTIC agents, OCCUPATIONAL roles, EXPERIMENTAL design, ENOXAPARIN, ACADEMIC medical centers, ANTICOAGULANTS, MEDICAL protocols, HOSPITAL care, DESCRIPTIVE statistics, PLATELET aggregation inhibitors, PATIENT compliance, LONGITUDINAL method

Geographic Terms: NETHERLANDS

Role of Drug-Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity.

Authors: Jessurun, Naomi T., Drent, Marjolein, Wijnen, Petal A., Harmsze, Ankie M., van Puijenbroek, Eugène P., Bekers, Otto, Bast, Aalt

Source: Drug Safety; Nov2021, Vol. 44 Issue 11, p1179-1191, 13p

Subject Terms: SIMVASTATIN, PULMONARY toxicology, PHARMACOGENOMICS, BIOCHEMICAL genetics, GENETIC engineering, PROTEINS, RESEARCH, ANTILIPEMIC agents, RESEARCH methodology, EVALUATION research, COMPARATIVE studies, DRUG interactions, OXIDOREDUCTASES, HEMOPROTEINS

Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients.

Authors: Harmsze, Ankie M.^1,2,3 (AUTHOR), Van Werkum, Jochem W.^2,4 (AUTHOR), Moral, Fulya³ (AUTHOR), Ten Berg, Jurriën M.^2,4 (AUTHOR), Hackeng, Christian M.^2,5 (AUTHOR), Klungel, Olaf H.³ (AUTHOR), De Boer, Anthonius³ (AUTHOR), Deneer, Vera H. M.^1,2 (AUTHOR) v.deneer@antoniusziekenhuis.nl

Source: Platelets. Mar2011, Vol. 22 Issue 2, p98-102. 5p. 1 Chart, 1 Graph.

Subject Terms: *SULFONYLUREAS, *CLOPIDOGREL, *HYPOGLYCEMIC agents, *TREATMENT of diabetes, *ADENOSINE diphosphate, *DRUG interactions

Patient's Estimation of Efficacy of Various Hyperhidrosis Treatments in a Dermatological Clinic.

Authors: Amini, Mohammad¹, Harmsze, Ankie M.², Tupker, Ron A.¹ r.tupker@antonius.net

Source: Acta Dermato-Venereologica. 2008, Vol. 88 Issue 4, p356-362. 7p.

Subject Terms: *HYPERHIDROSIS treatment, *QUALITY of life, *DERMATOLOGY, *PATIENTS, *SKIN diseases

Effect of oxybutynin on exercise-induced sweating in healthy individuals.

Authors: van Houte, Marthe¹ (AUTHOR), Harmsze, Ankie M.² (AUTHOR), Deneer, Vera H. M.² (AUTHOR), Tupker, Ron A.¹ (AUTHOR) r.tupker@antonius.net

Source: Journal of Dermatological Treatment. Apr2008, Vol. 19 Issue 2, p101-104. 4p. 1 Chart, 1 Graph.

Subject Terms: *PARASYMPATHOLYTIC agents, *DRUG side effects, *CAUSATION (Philosophy), *SWEATING-sickness, *SWEAT gland diseases, *PATIENTS, *HYPERHIDROSIS

Exercise-induced Sweating in Healthy Subjects as a Model to Predict a Drug's Sweat-reducing Properties in Hyperhidrosis: a Prospective, Placebo-controlled, Double-blind Study.

Authors: Harmsze, Ankie M.¹ a.harmsze@antoniusmesosgroep.nl, van Houte, Marthe², Deneer, Vera H. M.¹, Tupker, Ron A.²

Source: Acta Dermato-Venereologica. 2008, Vol. 88 Issue 2, p108-112. 5p.

Subject Terms: *DRUG efficacy, *PHARMACODYNAMICS, *EXERCISE physiology, *PLACEBOS, *PERSPIRATION, *HYPERHIDROSIS, *SWEAT gland diseases, *CLINICAL biochemistry, *MEDICAL experimentation on humans

This result is not displayed to guests.
Login for full access.

Severe pancytopenia and aspergillosis caused by thioguanine in a thiopurine S-methyltransferase deficient patient: a case report.

Authors: de Hoogd, Sjoerd, Wong, Dennis R., de Vries, Durk R., Harmsze, Ankie M.

Source: European Journal of Gastroenterology & Hepatology; Dec2019, Vol. 31 Issue 12, p1592-1596, 5p

Subdivision of aspirin tablets? Use your hands: a study on aspirin tablet subdivision using four different methods.

Authors: van Reuler, Alexandra V. R., van Diemen, Jeske J. K., Harmsze, Ankie M., Fuijkschot, Wessel W., Thijs, Abel

Source: Journal of Pharmacy Practice & Research; Feb2018, Vol. 48 Issue 1, p44-48, 5p, 2 Charts, 2 Graphs

Subject Terms: ASPIRIN, DRUG administration, DRUG tablets, DESCRIPTIVE statistics

This result is not displayed to guests.
Login for full access.